Duyuru • May 16
WW International, Inc.(OTCPK:WGHT.Q) dropped from NASDAQ Composite Index WW International, Inc. has been dropped from the NASDAQ Composite Index . Duyuru • May 12
Galloway Capital Partners, LLC Urges the Formation of An Official Equity Committee On May 6, 2025, WeightWatchers announced that it filed for Chapter 11 bankruptcy protection. Galloway Capital Partners, LLC believe that the interests of existing shareholders will not be adequately represented unless an Official Equity Committee is formed. Further, Galloway Capital argue that the bankruptcy filing is not due to exigent financial distress and that the current shareholders' interests need protection against the proposed plan of reorganization. Duyuru • May 10
WW International Receives a Written Notice from the Listing Qualifications Department of the Nasdaq Stock Market On May 9, 2025, WW International, Inc. received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined to delist the Company’s common stock as a result of the Company and certain of its subsidiaries commencing voluntary prepackaged cases under chapter 11 of title 11 of the United States Code, on May 6, 2025 (the “Chapter 11 Cases”). Pursuant to Nasdaq listing rules, the Company has the right to appeal Nasdaq’s delisting determination. The Notice further advises that Nasdaq will suspend trading of the Company’s common stock at the opening of business on May 16, 2025 and that Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission (the “SEC”) to effect the delisting of the Company’s common stock unless the Company requests an appeal of this determination. The Company intends to seek to list, on Nasdaq or another national stock exchange, the new common equity of the reorganized Company that is expected to be issued pursuant to the plan of reorganization for the Chapter 11 Cases on or as soon as possible after the emergence from the Chapter 11 Cases. The Company anticipates that following suspension from trading, its common stock will commence trading on the Pink Current Market, operated by OTC Markets Group. The transition to the over-the-counter market is not expected to affect the Company’s business operations. The Company can provide no assurance that the common stock will commence or continue to trade on this market, whether broker-dealers will continue to provide public quotes of the common stock on this market, whether the trading volume of the common stock will be sufficient to provide for an efficient trading market or whether quotes for the common stock will continue on this market in the future. Duyuru • May 09
Motion for Joint Administration Approved for WW International, Inc. The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of WW International, Inc. and its affiliates on May 8, 2025. The affiliates include WW North America Holdings, LLC, WW Canada Holdco, Inc., WW.com, LLC, W Holdco, Inc., WW Health Solutions, Inc., Weekend Health, Inc., and WW NewCo, Inc. The cases would be jointly administered for administrative and procedural purposes. WW International, Inc. has been designated as the lead debtor. New Risk • May 02
New major risk - Revenue and earnings growth Earnings have declined by 65% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (58% average weekly change). Earnings have declined by 65% per year over the past 5 years. Minor Risk Market cap is less than US$100m (US$58.3m market cap). Duyuru • Mar 23
WW International Receives Written Notice from Nasdaq Regarding Minimum Bid Price Requirement On March 19, 2025, WW International, Inc. received a written notice from the Nasdaq Listing Qualifications Department, notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), which requires the Company to maintain a minimum closing bid price of at least $1.00 per share for continued listing on The Nasdaq Global Select Market (the “Minimum Bid Requirement”). The Company’s failure to comply with the Minimum Bid Requirement was based on the Company’s common stock per share price being below the $1.00 threshold for a period of 30 consecutive trading days. Pursuant to the Nasdaq Letter, the Company has 180 calendar days from the date of the Nasdaq Letter to regain compliance. To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of 10 consecutive trading days prior to September 15, 2025. Neither the Nasdaq Letter nor the Company’s noncompliance with the Minimum Bid Requirement have an immediate effect on the listing or trading of the Company’s common stock, which will continue to trade on The Nasdaq Global Select Market under the symbol “WW.” The Company intends to actively monitor the closing bid price of its common stock and will consider available options to regain compliance with the Minimum Bid Requirement. New Risk • Mar 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risk Market cap is less than US$100m (US$51.3m market cap). Reported Earnings • Feb 28
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: US$4,344 loss per share (further deteriorated from US$1.46 loss in FY 2023). Revenue: US$785.9m (down 12% from FY 2023). Net loss: US$345.7m (loss widened 208% from FY 2023). Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) missed analyst estimates by 87%. Revenue is expected to decline by 4.2% p.a. on average during the next 3 years, while revenues in the Consumer Services industry in the US are expected to grow by 10%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance. Duyuru • Feb 24
WW International, Inc. to Report Q4, 2024 Results on Feb 27, 2025 WW International, Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025 Duyuru • Nov 27
WW International, Inc. Announces Chief Financial Officer Changes WW International, Inc. announced the appointment of Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025. She succeeds Heather Stark, who will remain with the Company through December 27, 2024. DellaFortuna is an accomplished financial leader with a track record of driving operational efficiency and fostering growth. As Chief Financial Officer of Enthusiast Gaming, a global gaming media platform, she led financial strategy and operations, driving the business to profitability and strengthening its balance sheet in the dynamic digital media sector. Previously, as Chief Financial Officer of BuzzFeed, Inc., DellaFortuna played a pivotal role in its transformation into one of the first profitable pure-play digital media companies. She diversified revenue streams and enhanced its growth strategy, unlocked synergies across business units, and led corporate development initiatives, including the acquisitions of Complex Networks and HuffPost. Earlier in her career, she held senior finance roles at Viant Technology Inc. and XIX Entertainment. DellaFortuna began her career at Ernst & Young in Transaction Advisory Services and Audit. A Certified Public Accountant, she brings deep expertise in navigating complex business environments with precision and discipline. Major Estimate Revision • Nov 13
Consensus EPS estimates fall by 70% The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -US$2.70 to -US$4.58 per share. Revenue forecast unchanged at US$775.8m. Consumer Services industry in the US expected to see average net income growth of 28% next year. Consensus price target of US$0.99 unchanged from last update. Share price fell 12% to US$0.91 over the past week. Reported Earnings • Nov 07
Third quarter 2024 earnings: EPS misses analyst expectations Third quarter 2024 results: US$0.58 loss per share (down from US$0.55 profit in 3Q 2023). Revenue: US$192.9m (down 10% from 3Q 2023). Net loss: US$46.2m (down 206% from profit in 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is expected to decline by 3.7% p.a. on average during the next 3 years, while revenues in the Consumer Services industry in the US are expected to grow by 10%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 10 percentage points per year, which is a significant difference in performance. Duyuru • Nov 06
WW International, Inc. Reiterates Revenues Guidance and Updates Operating Loss Guidance for the Full Year Fiscal 2024 WW International, Inc. reiterated revenue guidance and updated operating loss guidance for the full year fiscal 2024. For the period, the company reiterates revenue guidance of at least $770.0 million. The company updates operating loss guidance to not exceed $240.4 million. Duyuru • Oct 24
WW International, Inc. to Report Q3, 2024 Results on Nov 06, 2024 WW International, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 06, 2024 Duyuru • Oct 09
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications WeightWatchers announced the addition of compounded semaglutide into its offering, broadening eligible members' access to clinical weight management interventions that are underpinned by the comprehensive, science-backed, behavioral and lifestyle support that has helped millions of people reach and sustain their weight goals. Shortages of GLP-1 medications have plagued the market for more than two years, with patients often unable to find name-brand medications in stock at their local pharmacies. Over the last six months, roughly 45% of WeightWatchers Clinic members eligible for and prescribed a GLP-1 by their clinician have been denied coverage by their insurance after three prior authorization requests. Less than 40% of insurers cover GLP-1 medications for weight loss, leaving many individuals living with obesity without crucial financial support, and for those with coverage, more than half say their GLP-1 is still difficult to affordability. For drugs that appear on the FDA drug shortages list, the FDA allows compounding pharmacies to create compounded medications that are identical to, or nearly identical to the drug in shortage. WeightWatchers undertook an extensive and robust diligence process to select an FDA-registered 503B facility. A 503B must adhere to Current Good Manufacturing Practice (CGMP) regulations, which are the same manufacturing standards enforced by the FDA for all manufacturing facilities involved in the production of FDA-approved drugs. Every batch of the finished product from a 503B facility is tested for sterility and potency, among other things, before release. For more information about WeightWatchers' Compounded GLP-1 medication offering and due diligence process, the Company has published a comprehensive Transparency Report which can be found at ww.com/compounded-glp1-safety. WeightWatchers clinicians have the option to prescribe compounded semaglutide, if determined that the use of a GLP-1 weight-loss medication is appropriate for a patient. Eligible members can either use their insurance for brand-name medications or choose to self-pay for brand-name medications or compounded semaglutide. Only patients meeting clinical eligibility requirements will be prescribed a compounded GLP-1; the clinical eligibility requirements for compounded GLP-1s are the same as for brand-name medications. If prescribed, WeightWatchers members receive their compounded semaglutide within 1-3 business days. They can also request a Certificate of Analysis (COA) for their medication, which provides transparency as to how medications were tested and quality standards in place throughout the process. WeightWatchers continues to deliver a holistic care model of high-touch, accessible clinical solutions in combination with its comprehensive, science-backed behavioral programs, providing members with all of the tools and resources they need to reach and sustain their weight health goals. Duyuru • Sep 11
WeightWatchers Announces Executive Appointments WeightWatchers announced the appointments of Scott Honken as Chief Commercial Officer and Phillip Picardi as Chief Impact Officer. The two will collaborate, alongside the existing leadership team to redefine community engagement across all stakeholders, including a continued focus on B2B constituents of employers, payers, and health plans and expanding access through WeightWatchers for Business. As Chief Commercial Officer, Scott will oversee all B2B growth, operations, partnerships, and licensing in the Companys efforts to expand access to equitable care. He joins the team from Calibrate, where he served as Chief Commercial Officer. He has also held commercial leadership positions at Rightway and Livongo (now Teladoc Health) where he was responsible for forming and growing multimillion-dollar strategic partnerships, as well as roles at Catamaran (now Optum Rx) and Mayo Clinic Health Solutions. As Chief Impact Officer, Phillip will focus on building communities both inside and outside of WeightWatchers, helping to drive and scale the Company’s impact work as WeightWatchers expands its model of care. He will lead teams across brand marketing, communications, social impact, and employee experience. Prior to joining WeightWatchers, Phillip served as Chief Strategy Officer at the Los Angeles LGBT Center, the worlds large LGBTQ+ nonprofit, where he supported its mission to provide holistic care to individuals experiencing poverty or homelessness. Prior to this, Phillip spent over a decade in media, serving as the Editor-in-Chief of Out and editorial director of Allure. He is best known for his role as the Chief Content Officer of Teen Vogue, leading to its recognition as the fastest growing womens magazine in America for two years in a row. He also founded them, Cond Nasts first-ever LGBTQ+ publication. New Risk • Aug 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risk Market cap is less than US$100m (US$58.2m market cap). Major Estimate Revision • Aug 08
Consensus EPS estimates upgraded to US$2.70 loss, revenue downgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from US$845.3m to US$775.2m. 2024 losses expected to reduce from -US$4.05 to -US$2.70 per share. Consumer Services industry in the US expected to see average net income growth of 28% next year. Consensus price target down from US$5.02 to US$1.99. Share price fell 18% to US$0.73 over the past week. Reported Earnings • Aug 02
Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2024 results: EPS: US$0.29 (down from US$0.65 in 2Q 2023). Revenue: US$202.1m (down 11% from 2Q 2023). Net income: US$23.3m (down 54% from 2Q 2023). Profit margin: 12% (down from 22% in 2Q 2023). Revenue missed analyst estimates by 3.3%. Earnings per share (EPS) exceeded analyst estimates significantly. Revenue is expected to decline by 1.4% p.a. on average during the next 3 years, while revenues in the Consumer Services industry in the US are expected to grow by 9.8%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 8 percentage points per year, which is a significant difference in performance. Duyuru • Aug 01
WW International, Inc. Updates Earnings Guidance for the Full Fiscal Year 2024 WW International, Inc. updated earnings guidance for the full fiscal year 2024. For the year, the company expects revenue to be at least $770.0 million. Operating loss is expected to be at most $180.7 million. Price Target Changed • Jul 29
Price target decreased by 17% to US$4.14 Down from US$5.02, the current price target is an average from 6 analysts. New target price is 259% above last closing price of US$1.16. Stock is down 90% over the past year. The company is forecast to post a net loss per share of US$4.05 next year compared to a net loss per share of US$1.46 last year. Duyuru • Jul 19
WW International, Inc. to Report Q2, 2024 Results on Aug 01, 2024 WW International, Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 01, 2024 Recent Insider Transactions Derivative • May 19
CEO & Director exercised options and sold US$117k worth of stock On the 15th of May, Sima Sistani exercised options to acquire 61k shares at no cost and sold these for an average price of US$1.91 per share. This trade did not impact their existing holding. For the year to December 2022, Sima's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Sima has owned 143.48k shares directly. Company insiders have collectively sold US$659k more than they bought, via options and on-market transactions in the last 12 months. Price Target Changed • May 03
Price target increased by 33% to US$8.75 Up from US$6.58, the current price target is an average from 4 analysts. New target price is 319% above last closing price of US$2.09. Stock is down 78% over the past year. The company is forecast to post a net loss per share of US$0.12 next year compared to a net loss per share of US$1.46 last year. Major Estimate Revision • Apr 26
Consensus EPS estimates fall by 10% The consensus outlook for fiscal year 2024 has been updated. 2024 expected loss increased from -US$0.125 to -US$0.137 per share. Revenue forecast unchanged at US$847.0m. Consumer Services industry in the US expected to see average net income growth of 27% next year. Consensus price target down from US$6.58 to US$6.43. Share price fell 13% to US$1.59 over the past week. Duyuru • Apr 20
WW International, Inc. to Report Q1, 2024 Results on May 02, 2024 WW International, Inc. announced that they will report Q1, 2024 results After-Market on May 02, 2024 Duyuru • Apr 12
Weightwatchers Appoints New Executive Leaders WeightWatchers announced the appointment of new executives to the Company’s leadership team as it builds for the future, supporting its purpose to help people live healthier, longer: Donna Boyer, as Chief Product Officer, Jacquie Cooke, as General Counsel and Secretary, and Debra Benovitz who has been elevated to Chief Insights Officer. Donna Boyerwill join the Company as Chief Product Officer, effective May 1, to drive the WeightWatchers product mission and strategy across the member experience, and champion cohesion across the end-to-end consumer journey. Most recently, Donna was the Chief Product Officer at Teladoc Health, where she led the strategic shift from a single product to a multi-product portfolio organization. Donna joined Teladoc Health as the SVP of Product and Design in 2020 and was promoted to Chief Product Officer within six months. She was instrumental in the integration and expansion of multiple organic and acquired product lines as well as launching new product offerings. Prior to Teladoc Health, Donna served as VP of Product and Design at Stitch Fix shortly after the company’s IPO to build and operationalize its product functions while diversifying its product offerings. Prior to Stitch Fix, Donna was Head of Product for Airbnb’s Hosts & Homes and later led the development of Airbnb Plus. Donna spent her early career in product management at Hyperion, which was later acquired by Oracle, as well as Digital Think and Yahoo!. Jacquie Cooke has joined the Company as General Counsel and Secretary to bring forward her extensive legal background in biotechnology and significant experience in regulatory and compliance matters as it pertains to healthcare. Prior to joining WeightWatchers, Jacquie served as General Counsel and Privacy Officer at 23andMe where she helped scale the business, owning the legal, data protection and compliance functions. She helped to lead the company through its go-public transaction as well as its acquisition and integration of Lemonaid Health, a telehealth platform and digital pharmacy. She joined 23andMe as Associate General Counsel in 2015. Prior to 23andMe, Jacquie was Senior Commercial Counsel for Genomic Health, a provider of genomic-based diagnostic tests that help optimize cancer care. At Genomic Health, she served as advisor to commercial teams and led health care compliance globally. Jacquie spent her early career as an associate at Latham & Watkins. Debra Benovitzjoined WeightWatchers in 2014 as SVP of Global Consumer Insights to guide the WeightWatchers user experience across product and marketing with data-backed insights. She joined the Company’s leadership in 2015, and her role has become even more essential to guarantee all cross-functional touchpoints resonate with WeightWatchers members. Her recent promotion to Chief Insights Officer expands her role to oversee all science and clinical research, including WeightWatchers #1 doctor recommended Points Program. Debra’s cross-functional oversight ensures consumer needs are met with what WeightWatchers science and medical teams can responsibly deliver with sustainability and efficacy across behavioral and clinical interventions to help people with better health outcomes. With more than 30 years of consumer insights experience, Debra has made significant contributions to WeightWatchers, delivering strategic consumer insights that drive business growth. Prior to WeightWatchers, Debra served as Vice President, Global Consumer Insights at PepsiCo. She also served key leadership roles at LEGO and Dove. Duyuru • Apr 05
WW International, Inc., Annual General Meeting, May 09, 2024 WW International, Inc., Annual General Meeting, May 09, 2024, at 10:00 Eastern Standard Time. Agenda: To consider the election of the two nominees named in the attached Proxy Statement as members of the Board of Directors to serve for a three-year term as Class II directors; to The election of the two nominees named in the attached Proxy Statement as members of the Board of Directors to serve for a two-year term as Class I directors; to consider The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2024; to consider The approval of the amendment to the Company’s Amended and Restated Articles of Incorporation to delete various provisions related to the Company’s former controlling shareholder that are no longer applicable; and to discuss other matters. New Risk • Mar 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risk Shareholders have been diluted in the past year (12% increase in shares outstanding). Major Estimate Revision • Mar 06
Consensus EPS estimates fall by 188% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$923.3m to US$849.3m. Losses expected to increase from US$0.043 per share to US$0.13. Consumer Services industry in the US expected to see average net income growth of 32% next year. Consensus price target down from US$10.36 to US$6.58. Share price fell 13% to US$3.17 over the past week. Duyuru • Mar 01
WW International, Inc. Provides Earnings Guidance for the First Quarter of 2024 and Fiscal Year 2024 WW International, Inc. provided earnings guidance for the first quarter of 2024 and fiscal year 2024. For the quarter, the company expects revenue to be approximately $200 million and to have an operating loss of approximately $15 million. For the year, the company expects revenues to be in the range of $830.0 million to $860.0 million, reflecting a $55 million year-over-year headwind from the strategic decision to wind down the Company’s low-margin consumer products business. Operating Income to be in the range of $100.0 million to $110.0 million. Reported Earnings • Feb 29
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: US$1.46 loss per share (improved from US$3.58 loss in FY 2022). Revenue: US$889.6m (down 14% from FY 2022). Net loss: US$112.3m (loss narrowed 55% from FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 105%. Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Consumer Services industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 33 percentage points per year, which is a significant difference in performance. Price Target Changed • Feb 29
Price target decreased by 14% to US$9.40 Down from US$10.93, the current price target is an average from 5 analysts. New target price is 201% above last closing price of US$3.12. Stock is down 19% over the past year. The company is forecast to post a net loss per share of US$0.03 next year compared to a net loss per share of US$1.46 last year. Duyuru • Feb 29
WW International, Inc. Announces Oprah Winfrey Not Stands for Re-Election as Member of Board WW International, Inc. announced on February 26, 2024, Oprah Winfrey notified the Chairman of the Company’s Board of Directors that she would not be standing for re-election as a member of the Board at the Company’s 2024 annual meeting of shareholders, currently planned to be held on May 9, 2024. Her decision was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Immediately following the 2024 Annual Meeting, the size of the Board will be reduced from ten members to nine. Ms. Winfrey has served on the Company’s Board of Directors since 2015. Duyuru • Feb 15
WW International, Inc. to Report Q4, 2023 Results on Feb 28, 2024 WW International, Inc. announced that they will report Q4, 2023 results After-Market on Feb 28, 2024 Price Target Changed • Jan 23
Price target decreased by 7.3% to US$10.93 Down from US$11.79, the current price target is an average from 7 analysts. New target price is 138% above last closing price of US$4.59. Stock is up 14% over the past year. The company is forecast to post a net loss per share of US$0.71 next year compared to a net loss per share of US$3.58 last year. Recent Insider Transactions Derivative • Dec 06
General Counsel & Secretary notifies of intention to sell stock Michael Colosi intends to sell 46k shares in the next 90 days after lodging an Intent To Sell Form on the 30th of November. If the sale is conducted around the recent share price of US$7.30, it would amount to US$335k. Since March 2023, Michael's direct individual holding has increased from 32.35k shares to 45.90k. Company insiders have collectively sold US$616k more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Dec 05
General Counsel & Secretary recently sold US$327k worth of stock On the 1st of December, Michael Colosi sold around 46k shares on-market at roughly US$7.11 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$217k more than they bought in the last 12 months. Duyuru • Nov 30
WW International, Inc. Announces Michael F. Colosi, General Counsel and Secretary Would Be Leaving on December 29, 2023 On November 29, 2023, WW International, Inc. announced that Michael F. Colosi, General Counsel and Secretary of the Company, would be leaving the Company on December 29, 2023. In connection with his departure from the Company, on November 28, 2023, Mr. Colosi entered into an agreement with the Company regarding the termination of his employment. The material terms of the Agreement are as follows: (i) a lump-sum cash payment of $897,657 and (ii) continued employer contributions for health coverage under Company-sponsored health plans during the 12-month period following his departure. All of Mr. Colosi’s unvested equity awards as of the Departure Date will be forfeited. He will have the right to exercise any of his vested stock options within 90 days of the Departure Date. Mr. Colosi is subject to covenants with respect to non-competition and non-solicitation of employees of the Company for one year following the Departure Date as well as with respect to confidentiality for perpetuity. In the Agreement, Mr. Colosi released all claims against the Company and all of its affiliates, related entities, predecessors and successors. New Risk • Nov 03
New major risk - Revenue and earnings growth Earnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 64% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (12% increase in shares outstanding). Reported Earnings • Nov 03
Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2023 results: EPS: US$0.55 (up from US$2.93 loss in 3Q 2022). Revenue: US$214.9m (down 14% from 3Q 2022). Net income: US$43.7m (up US$249.8m from 3Q 2022). Profit margin: 20% (up from net loss in 3Q 2022). Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) exceeded analyst estimates significantly. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Consumer Services industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Duyuru • Nov 03
WW International, Inc. Updates Earnings Guidance Its Full Year Fiscal 2023 WW International, Inc. updated earnings guidance full year fiscal 2023. For the period, Revenues are expected to be at the low end of the previously provided range of $890.0 million to $910.0 million. Operating income is now expected to be in the range of $31.0 million to $43.0 million, compared to the previously provided range of $39.0 million to $51.0 million, due to increased anticipated restructuring charges. Duyuru • Oct 20
WW International, Inc. to Report Q3, 2023 Results on Nov 02, 2023 WW International, Inc. announced that they will report Q3, 2023 results After-Market on Nov 02, 2023 Duyuru • Oct 07
WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health WeightWatchers announced that WeightWatchers for Business has fully integrated WW's science-proven behavioral program with its virtual obesity clinic and medication management. The company now offers a full spectrum weight health platform designed for employers and health plans, that delivers individualized member pathways based on true clinical need. As prevalence of chronic diseases increases, organizations are challenged with higher costs, with experts predicting a 2-10% increase in insurance premiums in 20241. Among the many contributing factors are the increased utilization and cost of GLP-1 medications indicated for weight loss and diabetes. To help organizations navigate this new landscape, WeightWatchers for Business is building on its 30+ years of science-backed expertise in the employer-sponsored healthcare space with a complete cost management and utilization strategy that includes preventing progression and facilitating remission of weight-related conditions, as well as managing weight before, during, and after pharmacotherapy. WeightWatchers for Business utilizes evidence-based clinical pathways and step therapy with proprietary de-escalation protocols designed to drive clinically significant outcomes while controlling cost. The complete weight health platform includes: WW's science-proven behavior change program for sustained outcomes, including a program tailored for diabetes, as well as, later this year, a program tailored for those on GLP-1 medications; Robust virtual and in-real-life community; Coach support at scale; Integrated health insights; Virtual clinic care and medication management, including GLP-1s when appropriate, under the guidance of obesity medicine trained healthcare providers. Duyuru • Aug 25
WW International, Inc. Announces Executive Changes On August 23, 2023, WW International, Inc. announced that Amy Kossover resigned as Senior Vice President, Corporate Controller and Principal Accounting Officer of the Company and will leave the Company on September 1, 2023. Effective August 24, 2023, the Company appointed Nicole Haag, the Company’s Vice President, Internal Audit, as Corporate Controller and Principal Accounting Officer. Additionally, on August 21, 2023, the Compensation and Benefits Committee of the Board of Directors of the Company (the “Committee”) approved the following modifications to the compensation arrangements for Ms. Haag in connection with her assuming the role of Corporate Controller and Principal Accounting Officer. Nicole Haag. Nicole Haag, age 54, has served as the Company’s Vice President, Internal Audit since January 2016. Ms. Haag previously served as the Company’s Assistant Corporate Controller from May 2005 through January 2016 and also held other positions in the internal audit and finance departments of the Company during her tenure with the Company. Ms. Haag began her career in the Assurance audit practice at PricewaterhouseCoopers LLP and has also held corporate finance and internal audit positions with health services companies. Ms. Haag received a B.B.A. from Hofstra University’s School of Business, with a major in Accounting. Reported Earnings • Aug 04
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2023 results: EPS: US$0.65 (up from US$0.066 loss in 2Q 2022). Revenue: US$226.8m (down 16% from 2Q 2022). Net income: US$50.8m (up US$55.5m from 2Q 2022). Profit margin: 22% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates significantly. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Consumer Services industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance. Price Target Changed • Jul 26
Price target increased by 23% to US$9.70 Up from US$7.90, the current price target is an average from 5 analysts. New target price is 16% below last closing price of US$11.54. Stock is up 74% over the past year. The company is forecast to post a net loss per share of US$1.58 next year compared to a net loss per share of US$3.58 last year. Duyuru • Jul 23
WW International, Inc. to Report Q2, 2023 Results on Aug 03, 2023 WW International, Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 03, 2023 Major Estimate Revision • Jul 07
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -US$1.42 to -US$1.58 per share. Revenue forecast of US$919.4m unchanged since last update. Consumer Services industry in the US expected to see average net income growth of 48% next year. Consensus price target of US$7.90 unchanged from last update. Share price rose 23% to US$8.26 over the past week. Major Estimate Revision • May 26
Consensus EPS estimates fall by 24% The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -US$1.15 to -US$1.42 per share. Revenue forecast of US$919.4m unchanged since last update. Consumer Services industry in the US expected to see average net income growth of 22% next year. Consensus price target of US$7.90 unchanged from last update. Share price fell 11% to US$7.16 over the past week. Recent Insider Transactions • May 18
Independent Director recently bought US$110k worth of stock On the 11th of May, Denis Kelly bought around 16k shares on-market at roughly US$6.86 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$1.0m more in shares than they have sold in the last 12 months. Duyuru • May 16
WW International, Inc. Appoints Tara Comonte to the Board of Directors, Effective as of June 1, 2023 WW International, Inc. known as WeightWatchers, announced that Tara Comonte, CEO of TMRW Life Sciences, Inc. (TMRW), has been appointed to the WeightWatchers Board of Directors, effective as of June 1, 2023. TMRW Life Sciences is a fast-growing technology company operating in the reproductive health sector. Named Fast Company's #1 Most Innovative Biotech company in 2022, TMRW created the world's first and only FDA-cleared, automated platform for the safe management of frozen eggs and embryos used in vitro fertilization. Prior to TMRW, Ms. Comonte served as Shake Shack's President and Chief Financial Officer, where she led the implementation of customer-first digital and technology solutions, resulting in significant value creation. Prior to that, she held various financial and operational C-level positions at large public and private equity-owned media companies, including Getty Images and McCann Worldgroup. In addition to serving on TMRW’s Board of Directors, Ms. Comonte is also on the Board of Strava, the leading subscription platform for connected fitness. Comonte's appointment follows the recent election of Tracey Brown, EVP and President of Retail and U.S. Chief Customer Officer at Walgreens and the former CEO of the American Diabetes Association. Director Christopher Sobecki will step down from the Board of Directors effective May 31, 2023, after serving on the Board since Artal’s acquisition of WeightWatchers from Heinz in 1999. Major Estimate Revision • May 11
Consensus EPS estimates fall by 378% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$931.4m to US$919.8m. Losses expected to increase from US$0.24 per share to US$1.15. Consumer Services industry in the US expected to see average net income growth of 22% next year. Consensus price target up from US$7.60 to US$7.90. Share price rose 12% to US$8.30 over the past week. Price Target Changed • May 07
Price target increased by 9.7% to US$7.90 Up from US$7.20, the current price target is an average from 5 analysts. New target price is 15% below last closing price of US$9.29. Stock is down 5.5% over the past year. The company is forecast to post a net loss per share of US$0.89 next year compared to a net loss per share of US$3.58 last year. Reported Earnings • May 06
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2023 results: US$1.68 loss per share (further deteriorated from US$0.12 loss in 1Q 2022). Revenue: US$241.9m (down 19% from 1Q 2022). Net loss: US$118.7m (loss widened US$110.4m from 1Q 2022). Revenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) missed analyst estimates significantly. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 9.2% growth forecast for the Consumer Services industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Duyuru • May 05
Ww International, Inc. Provides Earnings Guidance for Full Year 2023 WW International, Inc. provided earnings guidance for full year 2023. For the period, the company expects, Revenues are expected to be in the range of $910.0 million to $930.0 million. Operating income is expected to be in the range of $48.0 million to $60.0 million. Major Estimate Revision • May 01
Consensus EPS estimates upgraded to US$0.24 loss The consensus outlook for fiscal year 2023 has been updated. 2023 losses forecast to reduce from -US$0.36 to -US$0.24 per share. Revenue forecast steady at US$922.0m. Consumer Services industry in the US expected to see average net income growth of 31% next year. Consensus price target up from US$7.20 to US$7.60. Share price rose 16% to US$8.77 over the past week. Price Target Changed • Mar 28
Price target decreased by 14% to US$4.86 Down from US$5.63, the current price target is an average from 5 analysts. New target price is 20% above last closing price of US$4.06. Stock is down 62% over the past year. The company is forecast to post a net loss per share of US$0.35 next year compared to a net loss per share of US$3.58 last year. Recent Insider Transactions Derivative • Mar 24
CEO & Director exercised options and sold US$184k worth of stock On the 21st of March, Sima Sistani exercised options to acquire 41k shares at no cost and sold these for an average price of US$4.43 per share. This trade did not impact their existing holding. Since December 2022, Sima has owned 63.94k shares directly. Company insiders have collectively bought US$402k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Mar 07
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: US$3.58 loss per share (down from US$0.96 profit in FY 2021). Revenue: US$1.04b (down 14% from FY 2021). Net loss: US$251.4m (down 476% from profit in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 13%. Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Consumer Services industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 52 percentage points per year, which is a significant difference in performance. Duyuru • Feb 03
Ww International, Inc. Launches Innovative ESG Clarified Platform WW International, Inc. introduced ESG Clarified, an analytics platform generating new insights to help organizations better understand and address their climate, sustainability and wider ESG risks and exposures. The rapidly evolving ESG landscape presents multiple challenges for organizations as they seek to communicate their ESG strategy and manage associated risks. The ability to understand and effectively manage multiple data sources is central to empowering organizations to make informed and smarter decisions. ESG Clarified offers a comprehensive, analytical solution, underpinned by multiple validated data sources to assist with trending insight, scenario analysis and reporting. ESG Clarified incorporates an extensive set of external and proprietary internal data sources into a self service SaaS analytical solution, allowing clients to analyze and score their ESG exposures in real time to understand financial, human capital, and reputational metrics. This new platform affords clients the opportunity to benchmark their ESG risks against peers, while also generating reports about their related exposures that can be instrumental in discussions with insurance carriers as they build their risk programs. Duyuru • Jan 17
WW International, Inc. Appoints Tony Yen as Head of Taiwan WW International, Inc. announced the appointment of Tony Yen as Head of Taiwan, effective 1 January 2023. Tony succeeds Charles Wang who retired in December 2022. Tony brings with him over 20 years of risk engineering, risk management and insurance broking experience, and joined WTW in 2015. He also heads WTW's Corporate Risk & Broking (CRB) business in Taiwan and has helped many Taiwanese companies in developing their business continuity and enterprise risk management programmes. In his new role, Tony will work closely with business leaders across WTW to facilitate service delivery and drive growth in Taiwan. Duyuru • Jan 13
WTW Announces Executive Changes WTW announced the combination of its Asia and Australasia operations into one Asia Pacific region, effective 1 January 2023. As part of the combination, former Head of Australasia Simon Weaver has taken on the new role as Head of Asia Pacific. Based in Australia, Simon is responsible for driving business growth throughout the newly integrated region, enabling closer collaboration across the businesses to deliver superior advice, broking and solutions in the areas of people, risk and capital to organizations in the region. The current Head of Asia, Clare Muhiudeen, will retire from WTW in February 2023. Clare will work closely with Simon to ensure a smooth transition. Reporting to Pamela Thomson-Hall, Head of International at WTW, Simon will continue to hold his existing role as Head of Corporate Risk and Broking (CRB) in Asia Pacific. Simon brings with him over 30 years of risk management and insurance broking industry expertise across the UK, Asia and Australasia. Simon joined WTW in 2015 as head of Singapore and South East Asia and subsequently led the CRB business in Asia and Australasia regions respectively before assuming his current position in 2018. Price Target Changed • Jan 09
Price target decreased to US$5.74 Down from US$6.24, the current price target is an average from 8 analysts. New target price is 24% above last closing price of US$4.64. Stock is down 68% over the past year. The company is forecast to post a net loss per share of US$3.17 compared to earnings per share of US$0.96 last year. Recent Insider Transactions • Nov 23
CEO & Director recently bought US$250k worth of stock On the 18th of November, Sima Sistani bought around 64k shares on-market at roughly US$3.91 per share. This trade did not impact their existing holding. In the last 3 months, there was an even bigger purchase from another insider worth US$320k. This was Sima's only on-market trade for the last 12 months. Price Target Changed • Nov 17
Price target decreased to US$6.24 Down from US$8.53, the current price target is an average from 8 analysts. New target price is 47% above last closing price of US$4.25. Stock is down 80% over the past year. The company is forecast to post a net loss per share of US$2.39 compared to earnings per share of US$0.96 last year. Recent Insider Transactions • Nov 17
Independent Chairman of the Board recently bought US$320k worth of stock On the 10th of November, Raymond Debbane bought around 75k shares on-market at roughly US$4.27 per share. This transaction increased Raymond's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Raymond's only on-market trade for the last 12 months. 
